Pasithea Therapeutics Corp. Gains 46.48%
Mon, Nov 24, 2025 at 07:37 PM
Pasithea Therapeutics Corp. (KTTA:NASDAQ) soared at $0.42, representing a gain of 46.5%. The stock got featured on our News Catalysts scanner on Mon, Nov 24, 2025 at 08:12 AM in the 'BIOTECH' category. From Tue, Nov 11, 2025, the stock recorded 33.33% Up Days and 20.00% Green Days
About Pasithea Therapeutics Corp. (KTTA:NASDAQ)
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Top 10 Gainers:
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 368.57%
- Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 109.09%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 46.48%
- ZJK Industrial Co., Ltd. (ZJK:NASDAQ), 40.68%
- Blue Foundry Bancorp (BLFY:NASDAQ), 40.03%
- Agroz Inc. (AGRZ:NASDAQ), 36.79%
- Binah Capital Group, Inc. (BCG:NASDAQ), 34.55%
- NextCure, Inc. (NXTC:NASDAQ), 34.25%
- Inspire Veterinary Partners, Inc. (IVP:NASDAQ), 33.33%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 30.77%